The Conference on Retroviruses and Opportunistic Infections (CROI) took place February 19-22 at the Summit Convention Center in Seattle. HPTN researchers presented eight abstracts covering HPTN 071, HPTN 083, HPTN 084, HPTN 084-01, and the HPTN Modelling Centre.
|
|
Title |
Presenter |
Type |
Monday, February 20 |
|
||
|
Population Impact of Expanding PrEP Usage in South Africa: Model Comparison Analysis |
Sarah Stansfield | Poster | |
Tuesday, February 21 |
|||
| HPTN 071 |
HIV Incidence Differences Measured by Serial Cross-Sectional Incidence Testing: HPTN 071 (PopART) |
Oliver Laeyendecker | Oral |
| HPTN 084 |
Cabotegravir Pharmacology in The Background of Delayed Injections in HPTN 084 |
Mark Marzinke | Oral |
| HPTN 083 and HPTN 084 |
The LEVI Syndrome: Characteristics of Early HIV Infection with Cabotegravir for PrEP |
Susan Eshleman | Oral |
| HPTN 083 |
Cabotegravir for HIV PrEP in U.S. Black Men and Transgender Women Who Have Sex with Men |
Hyman Scott | Oral |
| HPTN 084-01 |
CAB-LA for HIV Prevention in African Cisgender Female Adolescents |
Sybil Hosek |
Oral |
| HPTN 083 |
Pre-Exposure Prophylaxis Product Choice in U.S. Participants in HPTN 083 |
Meredith Clement |
Poster |
Wednesday, February 22 |
|||
| HPTN 083 |
Bone Density Changes with CAB-LA or TDC/FTC PrEP in MSM and TGW in HPTN 083 |
Todd Brown |
Poster |